New pain Drug's breast milk safety under microscope
NCT ID NCT07378865
First seen Feb 01, 2026 · Last updated May 12, 2026 · Updated 11 times
Summary
This study looks at how much of the pain medicine suzetrigine and its breakdown product enter breast milk. Twelve healthy women who are breastfeeding will take a single dose and provide milk samples. The goal is to estimate the dose a nursing baby might receive and check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON - Utah - Salt Lake City Office
RECRUITINGSalt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.